Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-028740)

Filing Details

Accession Number:: 0001179110-16-028740
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-17 13:21:04
Reporting Period:: 2016-08-16

Filing Date:: 2016-08-17
Accepted Time:: 2016-08-17 13:21:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896264	Usana Health Sciences Inc	USNA	Medicinal Chemicals & Botanical Products (2833)	870500306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1203343	Dave Wentz	3838 West Parkway Blvd Salt Lake City UT 84120	Co-C.e.o.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-16	16,104	$57.62	395,619	No	4	M	Direct
Common Stock	Disposition	2016-08-16	10,736	$131.05	384,883	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Settled Stock Appreciation Rights	Disposition	2016-08-16	28,750	$0.00	29	$57.62

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,750	2016-08-15	2018-03-15	No	4	M	Direct

Footnotes

The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II
Weighted average price $131.0530. Price range in multiple transactions was $131 to $131.2850 inclusively